Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Desoxo-palbociclib is a derivative compound of Palbociclib (P139900). Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
?您的位置：
